1. Market Research
  2. > Pathology
About 200 reports for Lymphoma (page 1)

Purchase Reports From Reputable Market Research Publishers

Anaplastic lymphoma kinase Non Small Cell Lung Cancer (ALK-NSCLC) - Epidemiology Forecast to 2030

  • $ 2850
  • May 2020
  • 100 pages

Anaplastic lymphoma kinase Non Small Cell Lung Cancer (ALK-NSCLC) - Epidemiology Forecast to 2030 ##.

  • Cancer
  • Lung Cancer
  • Lymphoma
  • Pathology
  • Spain

Peripheral T-Cell Lymphoma Epidemiology Forecast to 2030

  • $ 3750
  • July 2020
  • 100 pages

Anaplastic Large Cell Lymphoma (ALCL) ##. ##. ##.

  • Cancer
  • Lymphoma
  • Pathology
  • Spain
  • United States

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Spain

  • $ 1995
  • May 2019
  • 130 pages

Leading Market Position: Product Recall: GSK discontinued the global development of GSK-## in Phase I stage of development for relapsed or refractory small-cell lung cancer, as well as the development of GSK-## in Phase I stage of development for follicular lymphoma, diffuse large

  • Lymphoma
  • Medical Device
  • Medical Equipment
  • Pharmaceutical
  • Spain

Market Access, Pricing and Reimbursement of Oncology Medicines in the 5EU

  • $ 7995
  • September 2018
  • 162 pages

It is indicated for adult patients with R/ R DLBCL and primary mediastinal large B-cell lymphoma (PMBCL).

  • Cancer
  • Lymphoma
  • Oncology
  • Pharmaceutical
  • Spain

Acute Myeloid Leukemia - Epidemiology Forecast to 2029

  • $ 3995
  • June 2020
  • 37 pages

Acute Myeloid Leukemia - Epidemiology Forecast to 2029 Summary Acute myeloid leukemia (AML) is a cancer of the blood and bone marrow in which the bone marrow produces abnormal red blood cells, white blood ...

  • Cancer
  • Leukemia
  • Lymphoma
  • Spain
  • Forecast

2020 Spain Tumor Marker Testing Market: Supplier Shares, Volume and Sales Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers

  • $ 2450
  • May 2020
  • 565 pages

lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others.

  • Cancer
  • Lymphoma
  • Spain
  • Demand

2020 Spain Hospital Tumor Marker Testing Market: Supplier Shares by Test and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentstion Review, Emerging Opportunities

  • $ 2500
  • April 2020
  • 521 pages

lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others.

  • Cancer
  • Lymphoma
  • Pathology
  • Spain
  • Demand

2020 Spain Hospital Cancer Diagnostics Market Forecasts for Major Tumor Markers: Supplier Shares by Test, Competitive Landscape, Innovative Technologies, Instrumentation Review

  • $ 2500
  • April 2020
  • 521 pages

lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others.

  • Cancer
  • Lymphoma
  • Pathology
  • Spain
  • Forecast

2020 Spain Tumor Marker Testing Analyzers and Reagents: Supplier Shares and Strategies, Volume and Sales Segment Forecasts by Product--Competitive Profiles, Technology and Instrumentation Review, Opportunities for Suppliers

  • $ 3500
  • February 2020
  • 565 pages

lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others.

  • Cancer
  • Lymphoma
  • Spain
  • Demand

Hematology and Flow Cytometry Analyzers and Reagents Market, 2019-2023: Emerging Opportunities in the US, Europe, Japan--Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review

  • $ 15900
  • June 2019
  • 700 pages

Flow Cytometry TestsCell Surface Markers (CD##/ CD##/ TandB Lymphocytes, CD##, Others), Chemotherapy Monitoring (Leukemia/ Lymphoma, Others), HLA Typing, Sperm Analysis, Cell Cycle Kinetics, Cell Function Testing, Chromosomal Abnormalities, Fetal Cell Analysis, Granulocyte Functio

  • Lymphoma
  • Medical Biotechnology
  • Japan
  • Spain
  • Demand

Colorectal Cancer: Epidemiology Forecast to 2028

  • $ 3995
  • November 2019
  • 47 pages

TO DETERMINE THE DISTRIBUTION OF DIAGNOSED INCIDENT CASES OF CRC BY STAGE AT DIAGNOSIS IN SPAIN, A RETROSPECTIVE FOLLOW-UP STUDY OF INDIVIDUALS DIAGNOSED WITH CRC (EXCLUDING CASES WITH DEATH CERTIFICATE-ONLY INFORMATION AND LYMPHOMAS) DURING 2006-2011 WAS USED TO DETERMINE THE DISTRIBUTION

  • Cancer
  • Colorectal Cancer
  • Lymphoma
  • Pathology
  • Spain

2020 Spain Hematology and Flow Cytometry Lab and POC Market: Supplier Shares, Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers

  • $ 1850
  • April 2020
  • 255 pages

Flow Cytometry TestsCell Surface Markers (CD##/ CD##/ TandB Lymphocytes, CD##, Others), Chemotherapy Monitoring (Leukemia/ Lymphoma, Others), HLA Typing, Sperm Analysis, Cell Cycle Kinetics, Cell Function Testing, Chromosomal Abnormalities, Fetal Cell Analysis, Granulocyte Functio

  • Lymphoma
  • Medical Biotechnology
  • Spain
  • Demand
  • Market Shares

2024 Europe Hematology and Flow Cytometry Analyzers and Reagents Market: France, Germany, Italy, Spain, UK

  • $ 9500
  • July 2020
  • 450 pages

Flow Cytometry TestsCell Surface Markers (CD##/ CD##/ TandB Lymphocytes, CD##, Others), Chemotherapy Monitoring (Leukemia/ Lymphoma, Others), HLA Typing, Sperm Analysis, Cell Cycle Kinetics, Cell Function Testing, Chromosomal Abnormalities, Fetal Cell Analysis, Granulocyte Functio

  • Lymphoma
  • Medical Biotechnology
  • Europe
  • Spain
  • Demand

Spain Hospital Tumor Marker Forecasts for Major Tests: Supplier Shares by Test, Competitive Landscape, Innovative Technologies, Instrumentation Review

  • $ 2500
  • November 2019
  • 521 pages

lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others.

  • Cancer
  • Lymphoma
  • Spain

Spain Hospital Cancer Diagnostics Market Forecasts for Major Tumor Markers: Supplier Shares by Test, Competitive Landscape, Innovative Technologies, Instrumentation Review

  • $ 2500
  • November 2019
  • 521 pages

lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others.

  • Cancer
  • Lymphoma
  • Spain
  • Forecast

2020 Europe Hematology and Flow Cytometry Lab and POC Market: France, Germany, Italy, Spain, UK--Market Share Analysis, Country Segment Forecasts, Competitive Intelligence, Instrumentation Review, Technology Trends, Opportunities for Suppliers

  • $ 7500
  • April 2020
  • 450 pages

Flow Cytometry TestsCell Surface Markers (CD##/ CD##/ TandB Lymphocytes, CD##, Others), Chemotherapy Monitoring (Leukemia/ Lymphoma, Others), HLA Typing, Sperm Analysis, Cell Cycle Kinetics, Cell Function Testing, Chromosomal Abnormalities, Fetal Cell Analysis, Granulocyte Functio

  • Lymphoma
  • Medical Biotechnology
  • Molecular Diagnostics
  • Spain
  • Market Shares

2018 Global Hematology and Flow Cytometry Market: US, Europe, Japan--Analyzer and Consumable Supplier Shares, Segment Forecasts by Test and Country, Competitive Intelligence, Emerging Technologies, Latest Instrumentation, Opportunities for Suppliers

  • $ 15900
  • June 2018
  • 700 pages

Flow Cytometry TestsCell Surface Markers (CD##/ CD##/ TandB Lymphocytes, CD##, Others), Chemotherapy Monitoring (Leukemia/ Lymphoma, Others), HLA Typing, Sperm Analysis, Cell Cycle Kinetics, Cell Function Testing, Chromosomal Abnormalities, Fetal Cell Analysis, Granulocyte Functio

  • Lymphoma
  • Medical Biotechnology
  • Molecular Diagnostics
  • Spain
  • Demand

Spain Tumor Marker Testing Analyzers and Reagents Market, 2019-2023: Supplier Shares and Sales Segment Forecasts by Product--Competitive Intelligence, Technology and Instrumentation Review, Opportunities for Suppliers

  • $ 4350
  • July 2019
  • 565 pages

lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others.

  • Cancer
  • Lymphoma
  • Spain
  • Demand

EpiCast Report: Non-Hodgkin’s Lymphoma - Epidemiology Forecast to 2024

  • $ 3995
  • January 2016
  • 67 pages

This epidemiological analysis focuses specifically on four subtypes of B-cell NHL: follicular lymphoma, marginal zone lymphoma, diffuse large B-cell lymphoma (DLBCL), and mantle cell lymphoma.

  • Cancer
  • Lymphoma
  • Pathology
  • Spain
  • Forecast

Spain Tumor Marker Testing Market Shares, Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers, 2019-2023

  • $ 2450
  • July 2019
  • 565 pages

lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others.

  • Cancer
  • Lymphoma
  • Spain
  • Market Shares
View report >

Pharmaceutical Market in Spain

  • January 2018
  • 252 pages

The PTEMI was also involved in the ##th International Congress on Law and the Human Genome held on ##-## May in Bilbao, highlighting the substantial progress seen in recent years in clinical research into rare diseases in Spain, in particular in the area of leukaemia and lymphoma, as well a

  • Lymphoma
  • Pharmaceutical
  • Spain
  • Market Size
  • EFPIA company

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on